This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Myochrysine (2014-03-12)
- Starting date:
- March 12, 2014
- Posting date:
- March 21, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-38401
Recalled Products
Myochrysine
Reason
This product may have been exposed to temperatures outside of the recommended storage requirements. The safety and efficacy of these drugs may be impacted by the temperature excursion.
Note: only the units shipped from Canadadrugs.com to Pharmawest Pharmacy Ltd. are affected, not the entire lot.
Depth of distribution
Distributed to a pharmacy located in B.C. Canada and further distributed to end user in the United States.
Affected products
Myochrysine
DIN, NPN, DIN-HIM
DIN 01927604
Dosage form
Solution
Strength
Gold Sodium Thiomalate 50 mg/mL
Lot or serial number
1A0002
Companies
- Recalling Firm
-
CanadaDrugs.com LP
10 Terracon Place
Winnipeg
R2J 4G7
Manitoba
CANADA
- Marketing Authorization Holder
-
Sanofi Aventis (Canada) Inc.
2905 Louis R. Renaud Place
Laval
H7V 0A3
Quebec
CANADA